Alnylam Pharmaceuticals | ALNY - 売上総利益

株価
312.17
毎日の変更
1.07 0.34%
毎月
-5.22%
毎年
10.18%
Q1 予測
302.80




売上総利益 変化する 日付
Acadia Pharmaceuticals USD 257.76M 778K 2025-12
Agios Pharmaceuticals USD 18.09M 6.89M 2025-12
Alnylam Pharmaceuticals USD 829.31M 219.56M 2025-12
Amgen USD 6.48B 307M 2025-09
Arrowhead Research USD 256.47M 228.7M 2025-09
BioCryst Pharmaceuticals USD 153.05M 4.16M 2025-12
BioMarin Pharmaceutical USD 713.01M 81.81M 2025-12
Incyte USD 1.39B 118.68M 2025-12
Ionis Pharmaceuticals USD 195M 40M 2025-12
Moderna USD 226M 583M 2025-12
Neurocrine Biosciences USD 787.9M 7M 2025-12
Novartis USD 10.82B 694M 2025-09
PTC Therapeutics USD 148.38M 39.31M 2025-12
Regeneron Pharmaceuticals USD 3.3B 67M 2025-12
Sangamo BioSciences -2.39M 1.09M 2024-06
Sanofi EUR 8.45B 3.02B 2025-12
Sarepta Therapeutics USD 43.55M 204.36M 2025-12
Takeda JPY 790.55B 262.97B 2025-12
Tectonic Therapeutic USD 0 0 2025-03
Ultragenyx Pharmaceutical USD 178M 46.06M 2025-12
Vertex Pharmaceuticals USD 2.72B 62.4M 2025-12
Xencor USD 21M 22.61M 2025-09